Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

David Jason Hanson


  • Evp, Strategy, Corp Dev & Gc at Nuvasive Inc (NUVA), 2015-12-03
  • Evp,coo at Medicis Pharmaceutical Corp (MRX), 2012-12-14
  • Evp, Company Group Chairman at Valeant Pharmaceuticals International Inc. (VRX), 2012-12-13
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MRX $33.02 43,496 225,513 2012-08-17 Filing
MRX $36.50 27,607 244,979 2011-05-13 Filing
MRX $25.22 27,809 238,251 2010-05-13 Filing